Evidence map›Paper›PMID 32260565›Full record

ArticleInternational journal of molecular sciences2020

Effect of Pharmacological Inhibition of the Catalytic Activity of Phosphatases of Regenerating Liver in Early T Cell Receptor Signaling Dynamics and IL-2 Production.

Oscar Aguilar-Sopeña, Sara Hernández-Pérez, Sergio Alegre-Gómez, Patricia Castro-Sánchez, Alba Iglesias-Ceacero, John S Lazo, Pedro Roda-Navarro

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Oscar Aguilar-SopeñaDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
Sara Hernández-PérezDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
Sergio Alegre-GómezDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
Patricia Castro-SánchezDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
Alba Iglesias-CeaceroDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
John S LazoDepartments of Pharmacology and Chemistry, University of Virginia, Charlottesville, VA 22908, USA.ORCID 0000-0002-0645-4025
Pedro Roda-NavarroDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Spain and 12 de Octubre Health Research Institute (imas12), 28040 Madrid, Spain.
Universidad Complutense de Madrid · ESUniversity of Virginia · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI JOHN Hackett BUSHWELLER · 1987 to 2026
$72.1M
MINISTERIO DE ECONOMÍA, INDUSTRIA Y COMPETITIVIDAD RTC-2017-5944-1MINISTERIO DE ECONOMIA Y COMPETITIVIDAD SAF2016-75656-PNCI NIH HHS P30 CA044579
6 · The paper itself

Abstract

We have previously shown the delivery of phosphatase of regenerating liver-1 (PRL-1) to the immunological synapse (IS) and proposed a regulatory role of the catalytic activity of PRLs (PRL-1, PRL-2 and PRL-3) in antigen-induced IL-2 production. Nonetheless, the expression in T cells and delivery to the IS of the highly homologous PRL-3, as well as the role of the catalytic activity of PRLs in antigen-induced early signaling, has not been investigated. Here, the expression of PRL-3 protein was detected in primary CD4 T cells and in the CD4 T cell line Jurkat (JK), in which an overexpressed GFP-PRL-3 fluorescent fusion protein trafficked through the endosomal recycling compartment and co-localized with PLCγ1 signaling sites at the IS. Pharmacological inhibition was used to compare the role of the catalytic activity of PRLs in antigen-induced early signaling and late IL-2 production. Although the phosphatase activity of PRLs was not critical for early signaling triggered by antigen, it seemed to regulate signaling dynamics and was necessary for proper IL-2 production. We propose that enzymatic activity of PRLs has a higher significance for cytokine production than for early signaling at the IS. However, further research will be necessary to deeply understand the regulatory role of PRLs during lymphocyte activation and effector function.

Indexed as

Signal TransductionCD4-Positive T-LymphocytesCells, CulturedEndosomesEnzyme InhibitorsHumansIminesInterleukin-2Jurkat CellsLymphocyte ActivationNeoplasm ProteinsPhospholipase C gammaProtein Tyrosine PhosphatasesPyridinesReceptors, Antigen, T-CellEnzyme InhibitorsIminesInterleukin-2JMS-053Neoplasm ProteinsPhospholipase C gammaProtein Tyrosine PhosphatasesPTP4A3 protein, humanPyridinesReceptors, Antigen, T-Cellcytokine productionendosomal compartmentimmunological synapsephosphatase of regenerating liverTCR early signaling

Identifiers

PMID32260565
PMCPMC7177812
OpenAlexW3014992306

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.